Chemoprevention by Fruit Phenolic Compounds

  • Gary D. Stoner
  • Bruce C. Casto
Part of the Cancer Drug Discovery and Development book series (CDD&D)


This chapter summarizes available information on the chemopreventive effects of fruit phenolic compounds in various experimental systems. Emphasis is placed on the anticarcinogenic activity of these phenolics and their proposed mechanisms of action.


Gallic Acid Caffeic Acid Ellagic Acid Protocatechuic Acid Propyl Gallate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Macheix J-J, Fleuriet A, Billot J. Fruit Phenolics, CRC Press, Boca Raton, FL, 1990.Google Scholar
  2. 2.
    Mirvish SS, Cardesa A, Wallcave L, Shubik P. Induction of mouse lung adenomas by amines or ureas plus nitrite and by N-nitroso compounds: effect of ascorbate, gallic acid, thiocyanate, and caffeine. J Natl Cancer Inst 1975;55:633–636.PubMedGoogle Scholar
  3. 3.
    Hirose M, Ito T, Takahashi S, et al. Prevention by synthetic phenolic antioxidants of 2-amino-3, 8-dimethylimidazo [4,5-f] quinoxaline (MeIQx)- or activated MeIQx-induced mutagenesis and MeIQx-induced rat hepatocarcinogenesis, and role of antioxidant activity in the prevention of carcinogenesis. Eur J Cancer Prey 1998;7:223–241.Google Scholar
  4. 4.
    Soleas GJ, Grass L, Josephy PD, et al. A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin Biochem 2002;35:119–124.PubMedCrossRefGoogle Scholar
  5. 5.
    Gali HU, Perchellet EM, Klish DS, et al. Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate in vivo. Int J Cancer 1992;51:425–432.PubMedCrossRefGoogle Scholar
  6. 6.
    Tanaka T, Kawamori T, Ohnishi M, et al. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and postinitiation phases. Cancer Res 1994;54:2359–2365.PubMedGoogle Scholar
  7. 7.
    Ohnishi M, Yoshimi N, Kawamori T, et al. Inhibitory effects of dietary protocatechuic acid and costunolide on 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis. Jpn J Cancer Res 1997;88:111–119.PubMedCrossRefGoogle Scholar
  8. 8.
    Yoshioka K, Kataoka T, Hayashi T, et al. Induction of apoptosis by gallic acid in human stomach cancer KATO III and colon adenocarcinoma COLO 205 cell lines. Oncol Rep 2000;7:1221–1223.PubMedGoogle Scholar
  9. 9.
    Ohno Y, Fukuda K, Takemura G, et al. Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 1999;10:845–851.PubMedCrossRefGoogle Scholar
  10. 10.
    Serrano A, Palacios C, Roy G, et al. Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch Biochem Biophys 1998;350:49–54.PubMedCrossRefGoogle Scholar
  11. 11.
    Roy G, Lombardia M, Palacios C, et al. Mechanistic aspects of the induction of apoptosis by lauryl gallate in the murine B-cell lymphoma line Wehi 231. Arch Biochem Biophys 2000;383:206–214.PubMedCrossRefGoogle Scholar
  12. 12.
    Sakaguchi N, Inoue M, Isuzugawa K, et al. Cell deathinducing activity by gallic acid derivatives. Biol Pharm Bull 1999;22:471–475.PubMedCrossRefGoogle Scholar
  13. 13.
    Sakaguchi N, Inoue M, Ogihara Y. Reactive oxygen species and intracellular Ca2+, common signals for apoptosis induced by gallic acid. Biochem Pharmacol 1998;55:1973–1981.PubMedCrossRefGoogle Scholar
  14. 14.
    Aoki K, Ishiwata S, Sakagami H, et al. Modification of apoptosis-inducing activity of gallic acid by saliva. Anticancer Res 2001;21:1879–1883.PubMedGoogle Scholar
  15. 15.
    Isuzugawa K, Ogihara Y, Inoue M. Different generation of inhibitors against gallic acid-induced apoptosis produces different sensitivity to gallic acid. Biol Pharm Bull 2001;24:249–253.PubMedCrossRefGoogle Scholar
  16. 16.
    Isuzugawa K, Inoue M, Ogihara Y. Catalase contents in cells determine sensitivity to the apoptosis inducer gallic acid. Biol Pharm Bull 2001;24:1022–1026.PubMedCrossRefGoogle Scholar
  17. 17.
    Saeki K, Hayakawa S, Noro T, et al. Apoptosis-inducing activity of galloyl monosaccharides in human histiocytic lymphoma U937 cells. Planta Med 2000;66:124–126.PubMedCrossRefGoogle Scholar
  18. 18.
    Vieira O, Escargueil-Blanc I, Meilhac O, et al. Effect of dietary phenolic compounds on apoptosis of human cultured endothelial cells induced by oxidized LDL. Br J Pharmacol 1998;123:565–573.PubMedCrossRefGoogle Scholar
  19. 19.
    Baer-Dubowska W, Szaefer H, Krajka-Kuzniak V. Inhibition of murine hepatic cytochrome P450 activities by natural and synthetic phenolic compounds. Xenobiotica 1998;28:735–743.PubMedCrossRefGoogle Scholar
  20. 20.
    Mahmoud NN, Carothers AM, Grunberger D, et al. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 2000;21:921–927.PubMedCrossRefGoogle Scholar
  21. 21.
    Mori H, Kawabata K, Yoshimi N, et al. Chemopreventive effects of ferulic acid on oral and rice germ on large bowel carcinogenesis. Anticancer Res 1999;19:3775–3778.PubMedGoogle Scholar
  22. 22.
    Hudson EA, Dinh PA, Kokubun T, et al. Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiol Biomark Prey 2000;9:1163–1170.Google Scholar
  23. 23.
    Makino T, Ono T, Muso E, Honda G. Inhibitory effect of Perilla frutescens and its phenolic constituents on cultured murine mesangial cell proliferation. Planta Med 1998;6:541–545.CrossRefGoogle Scholar
  24. 24.
    Chen YJ, Shiao MS, Wang SY. The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anticancer Drugs 2001;12:143–149.PubMedCrossRefGoogle Scholar
  25. 25.
    Chen YJ, Shiao MS, Hsu ML, et al. Effect of caffeic acid phenethyl ester, an antioxidant from propolis, on inducing apoptosis in human leukemic HL-60 cells. J Agric Food Chem 2001;49:5615–5619.PubMedCrossRefGoogle Scholar
  26. 26.
    Nardini M, Leonardi F, Scaccini C, Virgili F. Modulation of ceramide-induced NF-kappaB binding activity and apoptotic response by caffeic acid in U937 cells: comparison with other antioxidants. Free Radic Biol Med 2001;30:722–733.PubMedCrossRefGoogle Scholar
  27. 27.
    Weyant MJ, Carothers AM, Bertagnolli ME, Bertagnolli MM. Colon cancer chemopreventive drugs modulate integrin-mediated signaling pathways. Clin Cancer Res 2000;6:949–956.PubMedGoogle Scholar
  28. 28.
    Stoner GD, Mukhtar H. Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl 1995;22:169–180.CrossRefGoogle Scholar
  29. 29.
    Bate-Smith EC. Detection and determination of ellagitannins. Phytochemistry 1972;11:1153–1156.CrossRefGoogle Scholar
  30. 30.
    Daniel EM, Krupnick AS, Heur Y-H, et al. Extraction, stability, and quantitation of ellagic acid in various fruits and nuts. J Food Compos Anal 1989;2:338–349.CrossRefGoogle Scholar
  31. 31.
    Lesca P. Protective effects of ellagic acid and other plant phenols on benzo(a)pyrene-induced neoplasia in mice. Carcinogenesis 1983;4:1652–1653.CrossRefGoogle Scholar
  32. 32.
    Boukharta M, Jalbert G, Castonguay A. Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Nutr Cancer 1992;18:181–189.PubMedCrossRefGoogle Scholar
  33. 33.
    Mukhtar H, Das M, Del Tito BJ Jr, Bickers DR. Protection against 3-methylcholanthrene-induced skin tumorigenesis in BALB/c mice by ellagic acid. Biochem Biophys Res Commun 1984;119:751–757.PubMedCrossRefGoogle Scholar
  34. 34.
    Smart RC, Huang MT, Chang RL, et al. Effect of ellagic acid and 3-O-decylellagic acid on the formation of benzo(a)pyrene-derived DNA adducts in vivo and on the tumorigenicity of 3-methylcholanthrene in mice. Carcinogenesis 1986;7:1669–1675.PubMedCrossRefGoogle Scholar
  35. 35.
    Mandal S, Stoner GD. Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogenesis 1990;11:55–61.PubMedCrossRefGoogle Scholar
  36. 36.
    Daniel EM, Stoner GD. The effects of ellagic acid and 13-cis-retinoic acid on N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats. Cancer Lett 1991;56:117–124.PubMedCrossRefGoogle Scholar
  37. 37.
    Tanaka T, Iwata H, Niwa K, et al. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male AC1/N rats. Jpn J Cancer Res 1988;79:1297–1303.PubMedCrossRefGoogle Scholar
  38. 38.
    Narayanan BA, Geoffroy O, Willingham MC, et al. P53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett 1999;136:215–221.PubMedCrossRefGoogle Scholar
  39. 39.
    Saleem A, Husheem M, Harkonen P, Pihlaja K. Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit. J Ethnopharmacol 2002;31:327–336.CrossRefGoogle Scholar
  40. 40.
    Narayanan BA, Re GG. IGF-II down regulation associated cell cycle arrest in colon cancer cells exposed to phenolic antioxidant ellagic acid. Anticancer Res 2001;21:359–364.PubMedGoogle Scholar
  41. 41.
    Mistry KJ, Krishna M, Bhattacharya RK. Modulation of aflatoxin B1 activated protein kinase C by phenolic compounds. Cancer Lett 1997;121:99–104.PubMedCrossRefGoogle Scholar
  42. 42.
    Narayanan BA, Narayanan NK, Stoner GD, Bullock BP. Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life Sci 2002;70:1821–1839.PubMedCrossRefGoogle Scholar
  43. 43.
    Harborne JB, Mabry TJ. The Flavonoids: Advances in Research. Chapman and Hall, London/New York, 1982.Google Scholar
  44. 44.
    Harborne JB, Mabry TJ, Mabry H. The Flavonoids. Chapman and Hall, London, 1975.Google Scholar
  45. 45.
    Wattenberg LW, Coccia JB, Galbraith AR. Inhibition of carcinogen-induced pulmonary and mammary carcinogenesis by chalcone administered subsequent to carcinogen exposure. Cancer Lett 1994;83:165–169.PubMedCrossRefGoogle Scholar
  46. 46.
    Wattenberg L. Chalcones, myo-inositol and other novel inhibitors of pulmonary carcinogenesis. J Cell Biochem Suppl 1995;22:162–168.PubMedCrossRefGoogle Scholar
  47. 47.
    Yamamoto S, Aizu E, Jiang H, et al. The potent anti-tumorpromoting agent isoliquiritigenin. Carcinogenesis 1991;12:317–323.PubMedCrossRefGoogle Scholar
  48. 48.
    De Vincenzo R, Scambia G, Benedetti Panici P, et al. Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationships. Anticancer Drug Des 1995;10:481–490.PubMedGoogle Scholar
  49. 49.
    Satomi Y. Inhibitory effects of 3′-methyl-3-hydroxy-chalcone on proliferation of human malignant tumor cells and on skin carcinogenesis. Int J Cancer 1993;55:506–514.PubMedCrossRefGoogle Scholar
  50. 50.
    Yit CC, Das NP. Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Lett 1994;82:65–72.PubMedCrossRefGoogle Scholar
  51. 51.
    Iwashita K, Kobori M, Yamaki K, Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotechnol Biochem 2000;64:1813–1820.PubMedCrossRefGoogle Scholar
  52. 52.
    De Vincenzo R, Ferlini C, Distefano M, et al. In vitro evaluation of newly developed chalcone analogues in human cancer cells. Cancer Chemother Pharmacol 2000;46:305–312.PubMedCrossRefGoogle Scholar
  53. 53.
    Yang EB, Zhang K, Cheng LY, Mack P. Butein, a specific protein tyrosine kinase inhibitor. Biochem Biophy Res Commun 1998;245:435–438.CrossRefGoogle Scholar
  54. 54.
    Tanaka S, Sakata Y, Morimoto K, et al. Influence of natural and synthetic compounds on cell surface expression of cell adhesion molecules, ICAM-1 and VCAM-1. Planta Med 2001;67:108–113.PubMedCrossRefGoogle Scholar
  55. 55.
    Breinholt V, Larsen JC. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem Res Toxicol 1998;11:622–629.PubMedCrossRefGoogle Scholar
  56. 56.
    Birt DF, Mitchell D, Gold B, et al. Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res 1997;17:85–91.PubMedGoogle Scholar
  57. 57.
    Birt DF, Walker B, Tibbels MG, Bresnick E. Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol. Carcinogenesis 1986;7:959–963.PubMedCrossRefGoogle Scholar
  58. 58.
    Wei H, Tye L, Bresnick E, Birt DF. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 1990;50:499–502.PubMedGoogle Scholar
  59. 59.
    Caltagirone S, Rossi C, Poggi A, et al. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 2000;87:595–600.PubMedCrossRefGoogle Scholar
  60. 60.
    Reddy KB, Krueger JS, Kondapaka SB, Diglio CA. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int J Cancer 1999;82:268–273.PubMedCrossRefGoogle Scholar
  61. 61.
    Tatsuta A, Iishi H, Baba M, et al. Suppression by apigenin of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin Exp Metastasis 2000;18:657–662.PubMedCrossRefGoogle Scholar
  62. 62.
    Lindenmeyer F, Li H, Menashi S, et al. Apigenin acts on the tumor cell invasion process and regulates protease production. Nutr Cancer 2000;39:139–147.CrossRefGoogle Scholar
  63. 63.
    Yin F, Giuliano AE, Van Herle AJ. Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid 1999:9:369–376.PubMedCrossRefGoogle Scholar
  64. 64.
    Hirano T, Oka K, Akiba M. Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75–1. Res Commun Chem Pathol Pharmacol 1989;64:69–78.PubMedGoogle Scholar
  65. 65.
    Casagrande F, Darbon JM. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK 1. Biochem Pharmacol 2001;61:1205–1215.PubMedCrossRefGoogle Scholar
  66. 66.
    Wang W, Heideman L, Chung CS, et al. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog 2000;28:102–110.PubMedCrossRefGoogle Scholar
  67. 67.
    Yin F, Giuliano AE, Law RE, Van Herle AJ. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res 2001;21:413–420.PubMedGoogle Scholar
  68. 68.
    Kobayashi T, Nakata T, Kuzumaki T. Effect of flavonoids on cell cycle progression in prostate cancer cells. Cancer Lett 2002;176:17–23.PubMedCrossRefGoogle Scholar
  69. 69.
    Sato F, Matsukawa Y, Matsumoto K, et al. Apigenin induces morphological differentiation and G2-M arrest in rat neuronal cells. Biochem Biophys Res Commun 1994;204:578–584.PubMedCrossRefGoogle Scholar
  70. 70.
    Kuo ML, Lin JK, Huang TS, Yang NC. Reversion of the transformed phenotypes of v-H-ras NIH3T3 cells by flavonoids through attenuating the content of phosphotyrosine. Cancer Lett 1994;87:91–97.PubMedCrossRefGoogle Scholar
  71. 71.
    Takahashi T, Kobori M, Shinmoto H, Tsushida T. Structureactivity relationships of flavonoids and the induction of granulocytic- or monocytic-differentiation in HL60 human myeloid leukemia cells. Biosci Biotechnol Biochem 1998;62:2199–2204.PubMedCrossRefGoogle Scholar
  72. 72.
    Yin F, Giuliano AE, Van Herle AJ. Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Res 1999;19:4297–4303.PubMedGoogle Scholar
  73. 73.
    Gupta S, Afaq F, Mukhtar H. Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun 2001;287:914–920.PubMedCrossRefGoogle Scholar
  74. 74.
    Gupta S, Afaq F, Mukhtar H. Involvement of nuclear factorkappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene 2002;21:3727–3738.PubMedCrossRefGoogle Scholar
  75. 75.
    Zand RS, Jenkins DJ, Diamandis EP. Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res Treat 2000;62:35–49.PubMedCrossRefGoogle Scholar
  76. 76.
    Wang C, Kurzer MS. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 1997;28:236–247.PubMedCrossRefGoogle Scholar
  77. 77.
    Wang C, Kurzer MS. Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nutr Cancer 1998;31:90–100.PubMedCrossRefGoogle Scholar
  78. 78.
    Rosenberg RS, Grass L, Jenkins DJ, et al. Modulation of androgen and progesterone receptors by phytochemicals in breast cancer cell lines. Biochem Biophys Res Commun 1998;248:935–939.PubMedCrossRefGoogle Scholar
  79. 79.
    Collins-Burow BM, Burow ME, Duong BN, McLachlan JA. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms. Nutr Cancer 2000;38:229–244.PubMedCrossRefGoogle Scholar
  80. 80.
    Song DH, Sussman DJ, Seldin DC. Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells. J Biol Chem 2000;275:23,790–23,797.Google Scholar
  81. 81.
    Lin JK, Chen YC, Huang YT, Lin-Shiau SY. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin. J Cell Biochem Suppl 1997;28–29:39–48.PubMedCrossRefGoogle Scholar
  82. 82.
    Lee SC, Kuan CY, Yang CC, Yang SD. Bioflavonoids commonly and potently induce tyrosine dephosphorylation/inactivation of oncogenic proline-directed protein kinase FA in human prostate carcinoma cells. Anticancer Res 1998;18:1117–1121.PubMedGoogle Scholar
  83. 83.
    Uda Y, Price KR, Williamson G, Rhodes MJ. Induction of the anticarcinogenic marker enzyme, quinone reductase, in murine hepatoma cells in vitro by flavonoids. Cancer Lett 1997;120:213–216.PubMedCrossRefGoogle Scholar
  84. 84.
    Touraine RL, Vahanian N, Ramsey WJ, Blaese RM. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions. Hum Gene Ther 1998;9:2385–2391.PubMedCrossRefGoogle Scholar
  85. 85.
    van Rijn J, van den Berg J. Flavonoids as enhancers of x-rayinduced cell damage in hepatoma cells. Clin Cancer Res 1997;3:1775–1779.PubMedGoogle Scholar
  86. 86.
    Balasubramanian S, Govindasamy S. Inhibitory effect of dietary flavonol quercetin on 7,12-dimethylbenz[a] anthracene-induced hamster buccal pouch carcinogenesis. Carcinogenesis 1996;17:887–879.CrossRefGoogle Scholar
  87. 87.
    Elattar TM, Virji AS. The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res 2000;20:1733–1738.PubMedGoogle Scholar
  88. 88.
    Lee SF, Lin JK. Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells. Nutr Cancer 1997;28:177–183.PubMedCrossRefGoogle Scholar
  89. 89.
    Gee JM, Johnson IT. Polyphenolic compounds: interactions with the gut and implications for human health. Curr Med Chem 2001;8:1245–1255.PubMedCrossRefGoogle Scholar
  90. 90.
    Richter M, Ebermann R, Marian B. Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutr Cancer 1999;34:88–99.PubMedCrossRefGoogle Scholar
  91. 91.
    Wang IK, Lin-Shiau SY, Lin JK. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer 1999;35:1517–1525.PubMedCrossRefGoogle Scholar
  92. 92.
    Balabhadrapathruni S, Thomas TJ, Yurkow EJ, et al. Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells. Oncol Rep 2000;7:3–12.PubMedGoogle Scholar
  93. 93.
    Ishikawa Y, Kitamura M. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int 2000;58:1078–1087.PubMedCrossRefGoogle Scholar
  94. 94.
    Knowles LM, Zigrossi DA, Tauber RA, et al. Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutr Cancer 2000;38:116–122.PubMedCrossRefGoogle Scholar
  95. 95.
    Sestili P, Guidarelli A, Dacha M, Cantoni O. Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism. Free Radic Biol Med 1998;25:196–200.PubMedCrossRefGoogle Scholar
  96. 96.
    Tanaka T, Makita H, Ohnishi M, et al. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. Cancer Res 1997;57:246–252.PubMedGoogle Scholar
  97. 97.
    Tanaka T, Makita H, Ohnishi M, et al. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene. Cancer Res 1994;54:4653–4659.PubMedGoogle Scholar
  98. 98.
    Tanaka T, Kohno H, Murakami M, et al. Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juices rich in beta-cryptoxanthin and hesperidin. Int J Cancer 2000:88:146–150.PubMedCrossRefGoogle Scholar
  99. 99.
    Ogata S, Miyake Y, Yamamoto K, et al. Apoptosis induced by the flavonoid from lemon fruit (Citrus limon BURM.f.) and its metabolites in HL-60 cells. Biosci Biotechnol Biochem 2000;64:1075–1078.PubMedCrossRefGoogle Scholar
  100. 100.
    Habtemariam S. Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells. J Nat Prod 1997;60:775–778.PubMedCrossRefGoogle Scholar
  101. 101.
    Goswami R, Kilkus J, Scurlock B, Dawson G. CrmA protects against apoptosis and ceramide formation in PC 12 cells. Neurochem Res 2002;27:735–741.PubMedCrossRefGoogle Scholar
  102. 102.
    Liao YC, Liang WG, Chen FW, et al. IL-19 induced production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol 2002;169:4288–4297.PubMedGoogle Scholar
  103. 103.
    Nepka C, Asprodini E, Kouretas D. Tannins, xenobiotic metabolism and cancer chemoprevention in experimental animals. Eur J Drug Metab Pharmacokinet 1999;24:183–189.PubMedCrossRefGoogle Scholar
  104. 104.
    Baer-Dubowska W, Gnojkowski J, Fenrych W. Effect of tannic acid on benzo[a]pyrene-DNA adduct formation in mouse epidermis: comparison with synthetic gallic acid esters. Nutr Cancer 1997;29:42–47.PubMedCrossRefGoogle Scholar
  105. 105.
    Gali HU, Perchellet EM, Klish DS, et al. Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate in vivo. Int J Cancer 1992;51:425–432.PubMedCrossRefGoogle Scholar
  106. 106.
    Caderni G, Remy S, Cheynier V, et al. Effect of complex polyphenols on colon carcinogenesis. Eur J Nutr 1999;38:126–132.PubMedCrossRefGoogle Scholar
  107. 107.
    Bomser JA, Singletary KW, Wallig MA, Smith MA. Inhibition of TPA-induced tumor promotion in CD-1 mouse epidermis by a polyphenolic fraction from grape seeds. Cancer Lett 1999;135:151–157.PubMedCrossRefGoogle Scholar
  108. 108.
    Agarwal C, Sharma Y, Agarwal R. Anticarcinogenic effect of a polyphenolic fraction isolated from grape seeds in human prostate carcinoma DU145 cells: modulation of mitogenic signaling and cell-cycle regulators and induction of G1 arrest and apoptosis. Mol Carcinog 2000;28:129–138.PubMedCrossRefGoogle Scholar
  109. 109.
    Agarwal C, Sharma Y, Zhao J, Agarwal R. A polyphenolic fraction from grape seeds causes irreversible growth inhibition of breast carcinoma MDA-MB468 cells by inhibition mitogen-activated protein kinases activation and inducing G1 arrest and differentiation. Clin Cancer Res 2000;6:2921–2930.PubMedGoogle Scholar
  110. 110.
    Achiwa Y, Hibasami H, Katsuzaki H, et al. Inhibitory effects of persimmon (Diospyros kaki) extract and related polyphenol compounds on growth of human lymphoid leukemia cells. Biosci Biotechnol Biochem 1997;61:1099–1101.PubMedCrossRefGoogle Scholar
  111. 111.
    Schultze-Mosgau MH, Dale IL, Gant TW, et al. Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells. Eur J Cancer 1998;34:1425–1431.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Gary D. Stoner
  • Bruce C. Casto

There are no affiliations available

Personalised recommendations